Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,174 | 2,275 | 2,268 | 3,926 | 6,471 |
| Inventories | 113 | 128 | 74 | 74 | 59 |
| Other current assets | 131 | 366 | 366 | 273 | 273 |
| TOTAL | $6,535 | $2,976 | $2,952 | $4,378 | $6,950 |
| Non-Current Assets | |||||
| PPE Net | 236 | 219 | 239 | 259 | 273 |
| Other Non-Current Assets | 405 | 421 | 0 | 0 | 0 |
| TOTAL | $641 | $639 | $239 | $259 | $273 |
| Total Assets | $7,176 | $3,616 | $3,191 | $4,637 | $7,223 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,709 | 1,199 | 1,366 | 835 | 975 |
| TOTAL | $2,073 | $1,854 | $1,366 | $835 | $975 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 343 | 359 | 0 | 0 | 0 |
| TOTAL | $343 | $359 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,416 | $2,213 | $1,366 | $835 | $975 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -45,217 | -36,188 | -32,775 | -30,440 | -27,692 |
| Other shareholders' equity | 44 | 0 | 0 | 0 | 0 |
| TOTAL | $4,761 | $1,403 | $1,824 | $3,802 | $6,248 |
| Total Liabilities And Equity | $7,176 | $3,615 | $3,191 | $4,637 | $7,223 |